VAL201: Phase I/II data

An open-label, dose-escalation, U.K. Phase I/II trial in patients

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE